NCT04684602 - Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions | Biotech Hunter

Enrollment

5,000

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

July 9, 2030

Study Completion Date

December 9, 2030

Conditions

Autoimmune DiseasesCardiovascular DisordersDiabetes ComplicationsIntegumentary DiseaseMusculoskeletal DisordersNeurodegenerative DisordersNeurologic DisordersPulmonary DisordersSexual DysfunctionUrologic DisordersViral Illness

Interventions

BIOLOGICAL

PrimePro™/ PrimeMSK™

Injection via condition specific route of administration.

Trial Locations (1)

92032

RECRUITING

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City